WESTBOROUGH, Mass.--(BUSINESS WIRE)--GenomeQuest, Inc., a leader in sequence search for research and IP, today announced that it is providing its flagship GenomeQuest™ solution to ARYx Therapeutics, a privately-held pharmaceutical company with leading expertise and significant intellectual property in the area of retrometabolic drug design.
